AC Immune (ACIU) Non Operating Income (2015 - 2026)

AC Immune (ACIU) has 12 years of Non Operating Income data on file, last reported at -$16601.1 in Q1 2026.

• On a quarterly basis, Non Operating Income fell 104.38% year-over-year to -$16601.1 in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 62.97% increase from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 181.43% from the prior year.
• Non Operating Income for Q1 2026 stood at -$16601.1, down from $26274.6 in the prior quarter.
• Over the last five years, Non Operating Income for ACIU reached as high as $2.5 million in Q1 2024 and fell as low as -$2.2 million in Q2 2025.
• Historically, Non Operating Income has averaged -$208063.0 across 5 years, with a median of -$15159.3 in 2022.
• On a YoY basis, Non Operating Income climbed as much as 3732.21% in 2024 and fell as far as 928.09% in 2024.
• Year by year, Non Operating Income stood at -$51901.1 in 2022, then slumped by 399.59% to -$259291.5 in 2023, then slumped by 347.73% to -$1.2 million in 2024, then surged by 102.26% to $26274.6 in 2025, then sank by 163.18% to -$16601.1 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$16601.1 in Q1 2026, $26274.6 in Q4 2025, and $385033.7 in Q3 2025.